2Seventy Bio Earnings Estimate

By analyzing 2Seventy Bio's earnings estimates, investors can diagnose different trends across 2Seventy Bio's analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for 2Seventy Bio is based on EPS before non-recurring items and includes expenses related to employee stock options. 2Seventy Bio is projected to generate -0.179425 in earnings per share on the 31st of December 2024. 2Seventy Bio earnings estimates show analyst consensus about projected 2Seventy Bio EPS (Earning Per Share). It derives the highest and the lowest estimates based on 2Seventy Bio's historical volatility. Many public companies, such as 2Seventy Bio, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing 2Seventy Bio's earnings estimates, investors can diagnose different trends across 2Seventy Bio's analyst sentiment over time as well as compare current estimates against different timeframes. At this time, 2Seventy Bio's Gross Profit is comparatively stable compared to the past year. Gross Profit Margin is likely to gain to 0.96 in 2024, whereas Pretax Profit Margin is likely to drop (2.28) in 2024. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in 2Seventy Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. For more information on how to buy 2Seventy Stock please use our How to Invest in 2Seventy Bio guide.